Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72207 record(s)

Req # A-2019-001450

Adverse Reaction Report (AER). Report numbers: E2B_02671566, E2B_02671570, E2B_02671571, E2B_02672070.

Organization: Health Canada

66 page(s)
February 2020

Req # A-2019-001478

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-119610-635.

Organization: Health Canada

14 page(s)
February 2020

Req # A-2019-001488

Adverse Reaction Report (AER). Report number: E2B_02310500.

Organization: Health Canada

22 page(s)
February 2020

Req # A-2019-001492

Adverse Reaction Report (AER). Report number: E2B_02345483.

Organization: Health Canada

10 page(s)
February 2020

Req # A-2019-001533

Adverse Reaction Report (AER). Report numbers: E2B_01797022, E2B_02523318, E2B_01961659, E2B_02236249, E2B_02218726, E2B_00020158, 000725143, E2B_02384536, E2B_02596047.

Organization: Health Canada

143 page(s)
February 2020

Req # A-2019-001534

Adverse Reaction Report (AER) in relation to Nicotine. Report numbers: 000725632, E2B_ 01617862, E2B_ 02558497, E2B_ 02561919, E2B_ 02562515, E2B_ 02570365, E2B_02580206, E2B_ 02582811, E2B_ 02585524, E2B_ 02615391, E2B_ 02629703.

Organization: Health Canada

164 page(s)
February 2020

Req # A-2019-001540

Adverse Reaction Report (AER). Report number: 000725002.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001541

Adverse Reaction Report (AER). Report number: E2B_02465047.

Organization: Health Canada

14 page(s)
February 2020

Req # A-2019-001546

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02750326.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001555

Adverse Reaction Report (AER). Report number: E2B_02126749.

Organization: Health Canada

69 page(s)
February 2020
Date modified: